Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Butt

Showing results (641-650 of 661) with videos related to

Pageof 67
Sort By:
Eclinicalmedicine|August 3, 2023
Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational studySuelen H Qassim, Hiam Chemaitelly, Houssein H Ayoub, et al.
Vaccine|April 15, 2024
Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradientLayan Sukik, Hiam Chemaitelly, Houssein H Ayoub, et al.
Frontiers in Immunology|September 30, 2022
Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infectionsSuelen H Qassim, Mohammad R Hasan, Patrick Tang, et al.
Journal of Travel Medicine|September 30, 2022
Duration of immune protection of SARS-CoV-2 natural infection against reinfectionHiam Chemaitelly, Nico Nagelkerke, Houssein H Ayoub, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2017
Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney DonorsA D Muzaale, K N Althoff, C J Sperati, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 17, 2023
Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort studyHiam Chemaitelly, Jeremy Samuel Faust, Harlan M Krumholz, et al.
Journal of Travel Medicine|August 9, 2023
Bivalent mRNA-1273.214 vaccine effectiveness against SARS-CoV-2 omicron XBB* infectionsHiam Chemaitelly, Houssein H Ayoub, Sawsan AlMukdad, et al.
The New England Journal of Medicine|February 9, 2022
Protection against the Omicron Variant from Previous SARS-CoV-2 InfectionHeba N Altarawneh, Hiam Chemaitelly, Mohammad R Hasan, et al.
Iscience|May 31, 2021
SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individualsPeter V Coyle, Hiam Chemaitelly, Mohamed Ali Ben Hadj Kacem, et al.
Endoscopy|December 29, 2015
Reply to Kristo et alRehan J Haidry, Gideon Lipman, Matthew R Banks, et al.
Pageof 67

Showing results (641-650 of 661) with videos related to

Sort By:
Pageof 67
Eclinicalmedicine|August 3, 2023
Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational studySuelen H Qassim, Hiam Chemaitelly, Houssein H Ayoub, et al.
Vaccine|April 15, 2024
Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradientLayan Sukik, Hiam Chemaitelly, Houssein H Ayoub, et al.
Frontiers in Immunology|September 30, 2022
Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infectionsSuelen H Qassim, Mohammad R Hasan, Patrick Tang, et al.
Journal of Travel Medicine|September 30, 2022
Duration of immune protection of SARS-CoV-2 natural infection against reinfectionHiam Chemaitelly, Nico Nagelkerke, Houssein H Ayoub, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 13, 2017
Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney DonorsA D Muzaale, K N Althoff, C J Sperati, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 17, 2023
Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort studyHiam Chemaitelly, Jeremy Samuel Faust, Harlan M Krumholz, et al.
Journal of Travel Medicine|August 9, 2023
Bivalent mRNA-1273.214 vaccine effectiveness against SARS-CoV-2 omicron XBB* infectionsHiam Chemaitelly, Houssein H Ayoub, Sawsan AlMukdad, et al.
The New England Journal of Medicine|February 9, 2022
Protection against the Omicron Variant from Previous SARS-CoV-2 InfectionHeba N Altarawneh, Hiam Chemaitelly, Mohammad R Hasan, et al.
Iscience|May 31, 2021
SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individualsPeter V Coyle, Hiam Chemaitelly, Mohamed Ali Ben Hadj Kacem, et al.
Endoscopy|December 29, 2015
Reply to Kristo et alRehan J Haidry, Gideon Lipman, Matthew R Banks, et al.
Pageof 67